Product: FUT3 Antibody
Catalog: DF4068
Description: Rabbit polyclonal antibody to FUT3
Application: WB IHC IF/ICC
Reactivity: Human, Mouse
Mol.Wt.: 42 KD; 42kD(Calculated).
Uniprot: P21217
RRID: AB_2836442

View similar products>>

   Size Price Inventory
 100ul $280 In stock
 200ul $350 In stock

Lead Time: Same day delivery

For pricing and ordering contact:
Local distributors

Product Info

Source:
Rabbit
Application:
WB 1:500-1:1000, IHC 1:50-1:200, IF/ICC 1:100-1:500
*The optimal dilutions should be determined by the end user.
*Tips:

WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.

Reactivity:
Human,Mouse
Clonality:
Polyclonal
Specificity:
FUT3 Antibody detects endogenous levels of total FUT3.
RRID:
AB_2836442
Cite Format: Affinity Biosciences Cat# DF4068, RRID:AB_2836442.
Conjugate:
Unconjugated.
Purification:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
Storage:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
Alias:

Fold/Unfold

Alpha-(1,3/1,4)-fucosyltransferase; Blood group Lewis alpha-4-fucosyltransferase; CD174; FT3B; Fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group); Fucosyltransferase 3; Fucosyltransferase III; FucT III; FucT-III; FUT3; FUT3_HUMAN; Galactoside 3(4)-L-fucosyltransferase; LE; Les; Lewis FT;

Immunogens

Immunogen:
Uniprot:
Gene(ID):
Expression:
P21217 FUT3_HUMAN:

Highly expressed in stomach, colon, small intestine, lung and kidney and to a lesser extent in salivary gland, bladder, uterus and liver.

Sequence:
MDPLGAAKPQWPWRRCLAALLFQLLVAVCFFSYLRVSRDDATGSPRAPSGSSRQDTTPTRPTLLILLWTWPFHIPVALSRCSEMVPGTADCHITADRKVYPQADTVIVHHWDIMSNPKSRLPPSPRPQGQRWIWFNLEPPPNCQHLEALDRYFNLTMSYRSDSDIFTPYGWLEPWSGQPAHPPLNLSAKTELVAWAVSNWKPDSARVRYYQSLQAHLKVDVYGRSHKPLPKGTMMETLSRYKFYLAFENSLHPDYITEKLWRNALEAWAVPVVLGPSRSNYERFLPPDAFIHVDDFQSPKDLARYLQELDKDHARYLSYFRWRETLRPRSFSWALDFCKACWKLQQESRYQTVRSIAAWFT

PTMs - P21217 As Substrate

Site PTM Type Enzyme
Y209 Phosphorylation
Y210 Phosphorylation
Y222 Phosphorylation
Y316 Phosphorylation
T325 Phosphorylation

Research Backgrounds

Function:

May catalyze alpha-1,3 and alpha-1,4 glycosidic linkages involved in the expression of Vim-2, Lewis A, Lewis B, sialyl Lewis X and Lewis X/SSEA-1 antigens. May be involved in blood group Lewis determination; Lewis-positive (Le(+)) individuals have an active enzyme while Lewis-negative (Le(-)) individuals have an inactive enzyme. Also acts on the corresponding 1,4-galactosyl derivative, forming 1,3-L-fucosyl links.

Subcellular Location:

Golgi apparatus>Golgi stack membrane>Single-pass type II membrane protein.
Note: Membrane-bound form in trans cisternae of Golgi.

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionSubcellular location
Tissue Specificity:

Highly expressed in stomach, colon, small intestine, lung and kidney and to a lesser extent in salivary gland, bladder, uterus and liver.

Family&Domains:

Belongs to the glycosyltransferase 10 family.

Research Fields

· Metabolism > Glycan biosynthesis and metabolism > Glycosphingolipid biosynthesis - lacto and neolacto series.

· Metabolism > Global and overview maps > Metabolic pathways.

References

1). Terminal fucosylation of haptoglobin in cancer-derived exosomes during cholangiocarcinoma progression. Frontiers in Oncology, 2023 (PubMed: 37168374) [IF=4.7]

Application: IHC    Species: Human    Sample: CCA tissue

Figure 5 Fucosylation of EV-Hp is upregulated by CCA. (A) IHC staining of β-Hp in CCA tissue. Scale bar = 50 μm. IHC scores are shown. (B) IHC staining of TSG101 and CD63 in CCA tissue. Scale bar = 50 μm. IHC scores are shown. (C) IHC staining of FUT3 and FUT4 in CCA tissue. Scale bar = 50 μm. IHC score is shown. Quantitative data are shown as mean ± S.E.M. Statistical analysis was performed using the Mann-Whitney u-test. ****p < 0.0001, **p < 0.01, *p < 0.05, ns p > 0.05. ns, not significant.

2). Sialyl Lewis X mediates interleukin-1 beta-induced trophoblast adhesion to endometrial cells during human embryo implantation. Biology of Reproduction, 2023 (PubMed: 36648484) [IF=3.6]

Application: WB    Species: Human    Sample: RL95-2 cells

Figure 5 FUT3 knockdown in RL95-2 cells decreases the IL-1β induced spheroids adhesion and surface expression of sLeX. (A and B) RT-qPCR and western blot analysis indicated that FUT3 siRNA transfection significantly decreased the mRNA and protein expression of the target gene at both the basal and IL-1β (20 ng/ml) stimulated condition, n = 3 per group. (C) FUT3 knockdown decreased the basal and IL-1β induced spheroids adhesion to RL95-2 cells monolayer, n = 9 per group. The percentage of adhesion denotes the proportion of attached HTR-8/SVneo spheroids in the total number of initially transferred spheroids into each chamber. Raw data from the spheroids adhesion experiment can be found in Supplemental Table 2. (D and E) Flow cytometry suggested a substantial reduction of surface sLeX but not LeY expression by FUT3 siRNA transfection, n = 3 per group. Numbers by the representative histograms of isotype control IgM and specific sLeX/LeY staining indicate the positive cells (%). Data represent mean ± SEM. ANOVA followed by Tukey’s post hoc tests were performed for statistical analysis of three independent experiments. si-NC, non-target siRNA.

Restrictive clause

 

Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.

For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.